In a recent study, miR-103a-3p was identified as one of the upregulated miRNAs following the treatment of MSCs with MM-EVs [148]; in parallel, miR-129-5p, carried by MM-EVs, was found to reduce ALPL levels in MSCs. This evidence concerns the gene ALPL and Miyoshi myopathy.